Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renin and Renal Biomarker Response to Angiotensin II Versus Controls in Septic Shock
NCT04558359Phase 4Completed
- Start
- Oct 2020
- Primary completion
- Jul 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in septic shock, acute kidney injury (AKI). Started Oct 2020; status: completed.
02
Drugs
Angiotensin II
03
Conditions
septic shockacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04558359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558359.